Development and validation of a HPLC method for the determination of sertraline and three non-chiral related impurities

Journal of Pharmaceutical and Biomedical Analysis

Volumn 53, Issue 2, 2010, Pages 122-129

  Ferrarini, Alessia ^a,b   Huidobro, Angel Luis ^a   Pellati, Federica ^b   Barbas, Coral ^a  

^a UNIVERSIDAD SAN PABLO CEU   (Spain)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

HPLC; Method optimization; Pharmaceuticals; Validation

Indexed keywords

AMIDE; BUFFER; METHANOL; SERTRALINE; TABLET;

ARTICLE; DRUG DESIGN; DRUG DETERMINATION; DRUG FORMULATION; DRUG IMPURITY; DRUG SCREENING; DRUG STRUCTURE; EXPERIMENTAL DESIGN; FACTORIAL DESIGN; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PH; PRIORITY JOURNAL; TEMPERATURE; ULTRAVIOLET RADIATION; ANALOGS AND DERIVATIVES; CHEMISTRY; DEVICES; DRUG CONTAMINATION; ISOMERISM; PROCEDURES; TABLET; VALIDATION STUDY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG CONTAMINATION; ISOMERISM; SERTRALINE; TABLETS;

EID: 77953535375     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2010.01.036     Document Type: Article

References (26)

1. Boscha M.E., Sanchez A.J.R., Rojas F.S., Ojeda C.B. Analytical methodologies for the determination of sertraline. J. Pharm. Biomed. Anal. 2008, 48:1290-1302.
2. Hirano K., Kimura R., Sugimoto Y., Yamada J., Uchida S., Kato Y., Hashimoto H., Yamada S. Relationship between brain serotonin transporter binding, plasma concentration and behavioural effect of selective serotonin reuptake inhibitors. Br. J. Pharmacol. 2005, 144:695-702.
3. Wiener H.L., Kramer H.K., Reith M.E. Separation and determination of sertraline and its metabolite, desmethylsertraline, in mouse cerebral cortex by reversed-phase high-performance liquid chromatography. J. Chromatogr. 1990, 527:467-472.
4. Patel J., Spencer E.P., Flanagan R.J. HPLC of sertraline and norsertraline in plasma or serum. Biomed. Chromatogr. 1996, 10:351-354.
5. He L., Feng F., Wu J. Determination of sertraline in human plasma by high-performance liquid chromatography-electrospray ionization mass spectrometry and method validation. J. Chromatogr. Sci. 2005, 43:532-535.
6. Mandrioli R., Saracino M.A., Ferrari S., Berardi D., Kenndler E., Raggi M.A. HPLC analysis of the second-generation antidepressant sertraline and its main metabolite N-desmethylsertraline in human plasma. J. Chromatogr. B 2006, 836:116-119.
7. Rudberg I., Hermann M., Refsum H., Molden E. Serum concentrations of sertraline and N-desmethyl sertraline in relation to CYP2C19 genotype in psychiatric patients. Eur. J. Clin. Pharmacol. 2008, 64:1181-1188.
8. Patel B.N., Sharma N., Sanyal M., Shrivastav P.S. Analysis of second-generation antidepressant drug, sertraline and its active metabolite, N-desmethyl sertraline in human plasma by a sensitive and selective liquid chromatography-tandem mass spectrometry method. J. Chromatogr. B 2009, 877:221-229.
9. Casamenti G., Mandrioli R., Sabbioni C., Bugamelli F., Volterra V., Raggi M.A. Development of an HPLC method for the toxicological screening of central nervous system drugs. J. Liquid Chromatogr. 2000, 23:1039-1059.
10. Lucca A., Gentilini G., Lopez-Silva S., Soldarini A. Simultaneous determination of human plasma levels of four selective serotonin reuptake inhibitors by high-performance liquid chromatography. Ther. Drug Monit. 2000, 22:271-276.
11. Tournel G., Houdret N., Hedouin V., Deveaux M., Gosset D., Lhermitte M. High-performance liquid chromatographic method to screen and quantitate seven selective serotonin reuptake inhibitors in human serum. J. Chromatogr. B 2001, 761:147-158.
12. Frahnert C., Rao M.L., Grasmäder K. Analysis of eighteen antidepressants, four atypical antipsychotics and active metabolites in serum by liquid chromatography: a simple tool for therapeutic drug monitoring. J. Chromatogr. B 2003, 794:35-47.
13. Duverneuil C., de la Grandmaison G.L., de Mazancourt P., Alvarez J.C. A high-performance liquid chromatography method with photodiode-array UV detection for therapeutic drug monitoring of the nontricyclic antidepressant drugs. Ther. Drug Monit. 2003, 25:565-573.
14. Titier K., Castaing N., Scotto-Gomez E., Pehourcq F., Moore N., Molimard N. High-performance liquid chromatographic method with diode array detection for identification and quantification of the eight new antidepressants and five of their active metabolites in plasma after overdose. Ther. Drug Monit. 2003, 25:581-587.
15. Smyth W.F., Leslie J.C., McClean S., Hannigan B., McKenna H.P., Doherty B., Joyce C., O'Kane E. The characterisation of selected antidepressant drugs using electrospray ionisation with ion trap mass spectrometry and with quadrupole time-of-flight mass spectrometry and their determination by high-performance liquid chromatography/electrospray ionisation tandem mass spectrometry. Rapid Commun. Mass Spectrom. 2006, 20:1637-1642.
16. Kirchherrand H., Kuhn-Velten W.N. Quantitative determination of forty-eight antidepressants and antipsychotics in human serum by HPLC tandem mass spectrometry: a multi-level, single-sample approach. J. Chromatogr. B 2006, 843:100-113.
17. Malfará W.R., Bertucci C., Costa Queiroz M.E., Dreossi Carvalho S.A., Pires Bianchi Mde L., Cesarino E.J., Crippa J.A., Costa R.H., Queiroz Reliable HPLC method for therapeutic drug monitoring of frequently prescribed tricyclic and nontricyclic antidepressants. J. Pharm. Biomed. Anal. 2007, 44:955-962.
18. Esrafili A., Yamini Y., Shariati S. Hollow fiber-based liquid phase microextraction combined with high-performance liquid chromatography for extraction and determination of some antidepressant drugs in biological fluids. Anal. Chim. Acta 2007, 604:127-133.
19. Pathak A., Rajput S.J. Development of a stability-indicating high-performance liquid chromatographic method for the simultaneous determination of alprazolam and sertraline in combined dosage forms. J. AOAC Int. 2008, 91:1344-1353.
20. Reis M., Aamo T., Spigset O., Ahlner J. Serum concentrations of antidepressant drugs in a naturalistic setting: compilation based on a large therapeutic drug monitoring database. Ther. Drug Monit. 2009, 31:42-56.
21. Chen D.Y., Jiang S.M., Chen Y.Y., Hu Y.Z. HPLC determination of sertraline in bulk drug, tablets and capsules using hydroxypropyl-beta-cyclodextrin as mobile phase additive. J. Pharm. Biomed. Anal. 2004, 34:239-245.
22. Rao R.N., Talluri M.V., Maurya P.K. Separation of stereoisomers of sertraline and its related enantiomeric impurities on a dimethylated beta-cyclodextrin stationary phase by HPLC. J. Pharm. Biomed. Anal. 2009, 50:281-286.
23. Lucangioli S.E., Hermida L.G., Tripodi V.P., Rodriguez V.G., Lopez E.E., Rouge P.D., Carducci C.N. Analysis of cis-trans isomers and enantiomers of sertraline by cyclodextrin-modified micellar electrokinetic chromatography. J. Chromatogr. A 2000, 871:207-215.
24. Zhou M.X., Foley J.P. Analytical method for the quantitation of sertraline hydrochloride stereoisomers by electrokinetic chromatography. J. Chromatogr. A 2004, 1052:13-23.
25. Chen D., Chen Y., Hu Y. Optimized separation of cis-trans isomers and enantiomers of sertraline using cyclodextrin-modified micellar electrokinetic chromatography. Chromatographia 2004, 60:469-473.
26. International Conference on Harmonization of Technical Requirements for the Registration of Pharmaceuticals for Human Use (ICH) Guideline Q2(R1)-Validation of Analytical Procedures: Text and Methodology 2005, ICH Secretariat, c/o IFPMA, Geneva, pp. 1-13.